Literature DB >> 16097979

Impact of hypertensive disorders of pregnancy at term on infant birth weight.

Tze Kin Lau1, Man Wah Pang, Daljit S Sahota, Tse Ngong Leung.   

Abstract

This study was performed to investigate the impact of hypertensive disorders of pregnancy at term on neonatal birth weight. All singleton live births delivered between 37 and 42 weeks of gestation complicated by hypertensive disorders over a 7-year period (n = 362) was compared to 34 783 uncomplicated singleton deliveries in the same period. The individualized gestation-related optimal weight (GROW) was calculated for each individual case adjusted for the effects of maternal booking weight, height, parity, gestation at delivery, and fetal sex. Small-for-gestational-age (SGA) was defined as a birth weight less than the 10th percentile of the GROW. The incidence of SGA babies was significantly higher in subjects with preeclampsia and eclampsia than in control subjects (24.6 versus 11.3%; odds ratio = 2.55; 95% CI: 1.84, 3.55). Preeclampsia significantly reduced fetal birth weight by 130 g or 4.3%. Those with eclampsia on average had a neonatal birth weight 349 g or 11.0% below that of the GROW. In contrast, there was no significant difference in the incidence of SGA babies or degree of deviation from GROW between those with or without gestational hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 16097979     DOI: 10.1111/j.0001-6349.2005.00740.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Intrauterine growth standards: a cross-sectional study in a population of nigerian newborns.

Authors:  Olugbenga A Mokuolu; Omotayo O Adesiyun; Mohammed B Suleiman; Mustapha Bello
Journal:  Pediatr Rep       Date:  2012-09-28

2.  Impact of gestational hypertension and preeclampsia on low birthweight and small-for-gestational-age infants in China: A large prospective cohort study.

Authors:  Yingying Liu; Nan Li; Hang An; Zhiwen Li; Le Zhang; Hongtian Li; Yali Zhang; Rongwei Ye
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-28       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.